Metronidazole and antipyrine metabolism in the rat: Clearance determination from one saliva sample

References

• Allars H., Coleman M. D., Norton R. S. 1H nuclear magnetic resonance study of metronidazole metabolism by perfused rat liver. European Journal of Drug Metabolism and Pharmacokinetics 1985; 10: 253–260
   PubMed Web of Science ®Google Scholar
• Bachmann K., Schwartz J., Forney R., Jr, Jairegui L. Phenytoin as a probe of drug metabolism. Predicting clerance with a salivary sample. Pharmacology 1985a; 30: 145–152
   PubMed Web of Science ®Google Scholar
• Bachmann K., Schwartz J., Forney R., Jr, Jauregui L. Theophylline kinetics: dose dependency and single sample prediction of clearance. Pharmacology 1985b; 30: 136–144
   PubMed Web of Science ®Google Scholar
• Bachmann K., Yang C., Jahn D., Schwartz J. The use of single sample clearance estimates to probe hepatic drug metabolism in rats. I. Xenobiotica 1988; 18: 151–159
   PubMed Web of Science ®Google Scholar
• Breimer D. D. Interindividual variations in drug disposition: Clinical implications and methods of investigation. Clinical Pharmacokinetics 1983; 8: 371–377
   PubMed Web of Science ®Google Scholar
• Buttar H. S., Siddiqui W. H. Pharmacokinetics and metabolic disposition of 14C-metronidazole-derived radioactivity in rat after intravenous and intravaginal administration. Archives of Internal Pharmacodynamics 1980; 245: 4–19
   PubMedGoogle Scholar
• Capel I. D., Jenner M., Pinnock M. H., Dorell H. M., Williams D. C. The effect of isolation stress on some hepatic drug and carcinogen metabolizing enzymes in rats. Journal of Environmental Pathology and Toxicology 1980; 3: 337–344
   Google Scholar
• Chindavijac B., Belpaire F. M., De Smet F., Bogaert M. G. Alteration of the pharmacokinetics of propanolol and antipyrine elicited by indwelling catheters in the rat. Journal of Pharmacology and Experimental Therapeutics 1988; 246: 1075–1079
   PubMed Web of Science ®Google Scholar
• Danhof M., Krom D. P., Breimer D. D. Studies on the different metabolic pathways of antipyrine in rats: influence of phenobarbital and 3-methylcholanthrene treatment. Xenobiotica 1979; 9: 695–702
   PubMed Web of Science ®Google Scholar
• Døssing M., Poulsen H. E., Andreasen P. B., Tygstrup N. A simple method for determination of antipyrine clearance. Clinical Pharmacology and Therapeutics 1982; 32: 392–396
   PubMed Web of Science ®Google Scholar
• Døssing M., Vølund A., Poulsen H. E. Optimal sampling times for minimum variance of clearance determination. British Journal of Clinical Pharmacology 1983; 15: 231–235
   PubMed Web of Science ®Google Scholar
• Inaba T., Lucassen M., Kalow W. Antipyrine metabolism in the rat by three hepatic monooxygenases. Life Sciences 1980; 26: 1977–1983
   PubMed Web of Science ®Google Scholar
• Jung D., Shah A. Influence of malnutrition on the disposition of metronidazole in rats. Pharmaceutical Research 1986; 3: 352–355
   PubMed Web of Science ®Google Scholar
• Kahn G. C., Boobis A. R., Murray S., Davies D. S. Differential effects of 3-methylcholanthrene and phenobarbitone treatment on the oxidative metabolism of antipyrine in vitro by microsomal fractions of rat liver. Xenobiotica 1982; 12: 509–516
   PubMed Web of Science ®Google Scholar
• Larusso N. F., Lindmark D. G., Muller M. Biliary and renal excretion, hepatic metabolism, and hepatic subcellular distribution of metronidazole in the rat. Biochemical Pharmacology 1978; 27: 2247–2254
   PubMed Web of Science ®Google Scholar
• Loft S., Poulsen H. E. Metabolism of metronidazole and antipyrine in isolated rat hepatocytes: influence of sex and enzyme induction and inhibition. Biochemical Pharmacology 1989; 38: 1125–1136
   PubMed Web of Science ®Google Scholar
• Loft S., Døssing M., Poulsen H. E., Sonne J., Olesen K. L., Simonsen K., Andreasen P. B. Influence of dose and route of administration on disposition of metronidazole and its major metabolites. European Journal of Clinical Pharmacology 1986; 30: 467–473
   PubMed Web of Science ®Google Scholar
• Loft S., Sonne J., Poulsen H. E., Petersen K. T., Jørgensen B. G., Døssing. Inhibition and induction of metronidazole and antipyrine metabolism. European Journal of Clinical Pharmacology 1987; 32: 35–41
   PubMed Web of Science ®Google Scholar
• Loft S., Poulsen H. E., Sonne J., Døssing M. Metronidazole clearance: a one-sample method and influencing factors. Clinical Pharmacology and Therapeutics 1988; 43: 420–428
   PubMed Web of Science ®Google Scholar
• Pilsgaard H., Poulsen H. E. A one-sample method for antipyrine clearance determination in rats. Pharmacology 1984; 29: 110–116
   PubMed Web of Science ®Google Scholar
• Poulsen H. E., Pilsgaard H. Antipyrine metabolism during hepatic regeneration in the rat. Liver 1985; 5: 196–199
   PubMedGoogle Scholar
• Poulsen H. E., Loft S. Antipyrine as a model drug to study hepatic drug metabolizing capacity. Journal of Hepatolology 1988; 6: 374–382
   PubMed Web of Science ®Google Scholar
• Rhodes J. C., Houston J. B. Antipyrine metabolite kinetics in phenobarbital and β-naphthoflavone induced rats. Drug Metabolism and Disposition 1983; 11: 131–136
   PubMed Web of Science ®Google Scholar
• Rowland M. Application of clearance concepts to some literature data on drug metabolism in the isolated perfused liver preparation and in vivo. European Journal of Pharmacology 1972; 17: 352–356
   PubMed Web of Science ®Google Scholar
• Schellens J. H. M., Van DER Wart J. H. F., Danhof M., Van DER Velse E. A., Breimer D. D. Relationship between the metabolism of antipyrine, hexobarbital and theophylline in man assessed by a -cocktail’ approach. British Journal of Clinical Pharmacology 1988; 26: 373–384
   PubMed Web of Science ®Google Scholar
• Stambaugh J. E., Feo L. G., Manthei R. W. The isolation and identification of the urinary oxidative metabolites of metronidazole in man. Journal of Pharmacology and Experimental Therapeutics 1968; 161: 373–381
   PubMed Web of Science ®Google Scholar
• Teunissen M. W. E., Joeres R. P., Vermeulen N. P. E., Breimer D. D. Influence of 9-hydroxyellipticine and 3-methylcholanthrene treatment on antipyrine metabolite formation in rats in vivo. Xenobiotica 1983a; 13: 223–231
   PubMed Web of Science ®Google Scholar
• Teunissen M. W. E., Van Graft M., Vermeulen N. P. E., Breimer D. D. Influence of allylisopropylacetamide and phenobarbital treatment on in vivo antipyrine metabolite formation in rats. Xenobiotica 1983b; 13: 497–502
   PubMed Web of Science ®Google Scholar
• Teunissen M. W. E., Brorens I. O. N., De Langen H. J., Gerlings S. M., Breimer D. D. Correlation between in vivo antipyrine metabolite formation and theophylfine metabolism in rats. Pharmaceutical Research 1986; 3: 156–161
   PubMed Web of Science ®Google Scholar
• Van DER Graff M., Vermeulen N. P. E., Joeres R. P., Vlietstra T., Breimer D. D. Correlation between the in vivo metabolism of hexobarbital and antipyrine in rats. Journal of Pharmacology and Experimental Therapeutics 1983; 227: 459–465
   PubMed Web of Science ®Google Scholar
• Van Dyke R. A., Koistra K. L., Moses C. J., Powis G. Effect of inhalation anesthetics on antipyrine pharmacokinetics of mice. Biochemical Pharmacology 1987; 36: 1023–1027
   PubMed Web of Science ®Google Scholar
• Van Staiger C., Wang N. S., De Vries J., Weber E. Untersuchungen zur Wirkung von Metronidazol auf der Phenazon-Metabolismus. Arzneimittelforschung 1984; 34: 89–91
   PubMedGoogle Scholar
• Welch R. M., Deangelix R. L., Wingfield M., Tarmer T. W. Elimination of antipyrine from saliva as a measure of metabolism in man. Clinical Pharmacology and Therapeutics 1975; 18: 249–253
   PubMed Web of Science ®Google Scholar
• Wilkinson G. R. Clearance approaches in pharmacology. Pharmacological Reviews 1987; 39: 1–47
   PubMed Web of Science ®Google Scholar
• Wilson V. L., Larson R. E., Moldovan M. J. A. A non-invasive method for the study of hepatic drug metabolism in rodents: antineoplastic drug effects on antypyrine metabolism in mice. Chemico-Biological Interactions 1982; 40: 159–168
   PubMed Web of Science ®Google Scholar
• Wood M., Wood A. J. J. Contrasting effects of halothane, isoflurane, and enflurane on in vivo drug metabolism in the rat. Anesthesia and Analgesia 1984; 63: 709–714
   PubMed Web of Science ®Google Scholar